MEDIHUB STROKE and JLK stroke AI suite

Organization
JLK Inc. · South Korea
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

JLK Inc. (originally JLK Inspection Inc.) was founded on 14 February 2014 and is headquartered at JLK Tower in Gangnam-gu, Seoul, South Korea. The company develops medical imaging AI, with a focus on stroke, and also runs subsidiaries in the United States and Japan.

MEDIHUB STROKE is an AI platform that analyzes CT, CTA, CTP, MRI and MRA images for hemorrhagic and ischemic stroke, from the emergency room to chronic-phase prognosis, with a mobile app. The same product family includes dementia and cancer packages, MEDIHUB TELE for telemedicine and the Hello Data platform for medical data collection. Korean university hospitals are named as customers.

2. Highlighted features & specifications

  • Stroke imaging analysis: analyzes CT, CTA, CTP, MRI and MRA for hemorrhage and infarction.
  • Perfusion and occlusion tools: separate modules such as JLK-CTP, JLK-PWI and JLK-LVO appear in the approval history.
  • Dementia and cancer packages: multi-modal analysis covering X-ray, mammography, CT, MRI and pathology.
  • MEDIHUB TELE: users upload data, view AI results on mobile and request specialist consultation.
  • Hello Data: platform for collecting and processing medical AI data, extended to other industries.
  • Integrated platform: JLK-AILink is listed as an integrated medical AI platform in the FDA history.

3. Potential application

A provincial hospital in Vietnam can use stroke CT and CTP analysis to support thrombolysis or thrombectomy decisions in the emergency department. A tertiary hospital can link a tele-stroke network between central and district sites using the mobile consultation tool. Medical AI teams can use the data platform to prepare annotated imaging datasets.

4. Benefits

Covers the whole stroke pathway on one platform, from emergency imaging to prognosis. Holds regulatory approvals in Japan (PMDA), the United States (FDA) and Korea (MFDS) per the company history page. Mobile access to AI results supports remote consultation with specialists. Data tooling helps hospitals prepare medical data for AI projects.

6. Other information

Founded 2014 in Seoul. Entities in Cheongju (Korea), Santa Clara (USA) and Tokyo (Japan). Company history lists PMDA approvals 2021-12 to 2025-09, FDA clearances 2024-06 to 2025-03 and MFDS approvals from 2018. MEDIHUB TELE passed the Korean regulatory sandbox in May 2021.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us